Search results
Bristol Myers to cut 6% of workforce, trim drug pipeline
BioPharma Dive via Yahoo Finance· 10 hours agoIts third highest-grossing product, the multiple myeloma treatment Revlimid, already faces limited...
Europe approves new multiple myeloma therapy CARVYKTI
Investing.com· 4 days agoThe European Commission has granted approval to CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) for...
Ray Romano Says Starring on Everybody Loves Raymond with Peter Boyle Was 'Surreal': 'He Made Me Feel...
People Magazine· 7 days agoDuring a recent interview with PEOPLE, Romano, 66, discussed his early days with his former costar,...
Ray Romano Has Rated Each Episode of “Everybody Loves Raymond”:“ ”'I Got on a Little Kick There'...
People via Yahoo News· 2 days agoEverybody Loves Raymond ran from 1996 to 2005 for nine seasons, with a cast that included Romano,...
Sanofi (SNY) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 hours agoIt showed us how innovation can help to revitalize hemophilia and grow Sanofi's total share. Other launch medicines also did well in growth in absolute...
New study points to racial and social barriers that block treatment for multiple myeloma
Newswise· 3 days agoA UC Davis Health study reveals persistent racial and social disparities preventing access to autoHCT, a common bone marrow transplant treatment to halt the progression of multiple& ...
Wedbush Reiterates “Neutral” Rating for Fate Therapeutics (NASDAQ:FATE)
ETF DAILY NEWS· 16 hours agoFate Therapeutics (NASDAQ:FATE – Get Free Report)‘s stock had its “neutral” rating reissued by equities research analysts at Wedbush in a note issued to investors on Tuesday, Benzinga reports ...
Some 700,000 Brits To Get Free Covid-19 Booster Shots This Week
Forbes· 5 days agoStarting Monday, the elderly and those with weakened immune systems will be able to get a shot free...
Bristol-Myers (BMY) Q1 Loss Narrower Than Expected, Sales Beat
Zacks via Yahoo Finance· 4 hours agoBristol-Myers' (BMY) first-quarter 2024 loss is narrower than estimated. Sales surpass the consensus...
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
CNBC· 8 hours agoBristol Myers Squibb on Thursday reported first-quarter revenue that topped expectations as its...
